{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:57:34Z","timestamp":1793332654948,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.autrev.2023.103339","type":"journal-article","created":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T17:13:40Z","timestamp":1682010820000},"page":"103339","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Biomarkers in alopecia Areata: A systematic review and meta-analysis."],"prefix":"10.1016","volume":"22","author":[{"given":"Hiba","family":"Zaaroura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Gilding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathryn","family":"Sibbald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.autrev.2023.103339_bb0005","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s12016-017-8620-9","article-title":"Alopecia Areata: a comprehensive review of pathogenesis and management","volume":"54","author":"Tr\u00fceb","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"issue":"7","key":"10.1016\/j.autrev.2023.103339_bb0010","doi-asserted-by":"crossref","first-page":"628","DOI":"10.4065\/70.7.628","article-title":"Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989","volume":"70","author":"Safavi","year":"1995","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.autrev.2023.103339_bb0015","series-title":"With alopecia Areata: clinical implications","first-page":"1","author":"Sali","year":"2021"},{"issue":"1 PG-234-240","key":"10.1016\/j.autrev.2023.103339_bb0020","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/jocd.12970","article-title":"The profile of cytokines (IL-2, IFN-gamma, IL-4, IL-10, IL-17A, and IL-23) in active alopecia areata","volume":"19","author":"Gautam","year":"2020","journal-title":"J Cosmet Dermatol"},{"issue":"3","key":"10.1016\/j.autrev.2023.103339_bb0025","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3109\/09546634.2015.1093591","article-title":"Serum cytokine and chemokine profiles in patients with alopecia areata","volume":"27","author":"Bilgic","year":"2016","journal-title":"J Dermatolog Treat"},{"issue":"5","key":"10.1016\/j.autrev.2023.103339_bb0030","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/jdv.15489","article-title":"JAK inhibitors for alopecia areata: a systematic review and meta-analysis","volume":"33","author":"Phan","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.autrev.2023.103339_bb0035","doi-asserted-by":"crossref","first-page":"393","DOI":"10.5021\/ad.2019.31.4.393","article-title":"Increased circulating CXCL10 in non-segmental vitiligo concomitant with autoimmune thyroid disease and alopecia areata","volume":"31","author":"Zhang","year":"2019","journal-title":"Ann Dermatol"},{"issue":"5 PG-1631-1634.e13","key":"10.1016\/j.autrev.2023.103339_bb0040","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.jaci.2018.06.029","article-title":"An integrated model of alopecia areata biomarkers highlights both TH1 and TH2 upregulation","volume":"142","author":"Song","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2023.103339_bb0045","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/pcmr.12559","article-title":"Differential expression of CXCL9, CXCL10, and IFN-\u03b3 in vitiligo and alopecia areata patients","volume":"30","author":"Maouia","year":"2017","journal-title":"Pigment Cell Melanoma Res"},{"issue":"1 PG-40-6","key":"10.1016\/j.autrev.2023.103339_bb0050","first-page":"40","article-title":"Differential expression of CXCL1, CXCL9, CXCL10 and CXCL12 chemokines in alopecia areata","volume":"10","author":"Zainodini","year":"2013","journal-title":"Iran J Immunol"},{"issue":"5 PG-742-747","key":"10.1016\/j.autrev.2023.103339_bb0055","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jaad.2013.05.020","article-title":"Clinical significance of serum high-mobility group box 1 level in alopecia areata","volume":"69","author":"Lee","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"3 PG-248-252","key":"10.1016\/j.autrev.2023.103339_bb0060","doi-asserted-by":"crossref","first-page":"248","DOI":"10.5114\/ada.2017.67847","article-title":"25-hydroxyvitamin D status in patients with alopecia areata","volume":"34","author":"Erpolat","year":"2017","journal-title":"Postep Dermatol Alergol"},{"key":"10.1016\/j.autrev.2023.103339_bb0065","article-title":"Evaluation of several immune and inflammatory indicators and their association with alopecia areata","volume":"101130964PG","author":"Gao","year":"2021","journal-title":"J Cosmet Dermatol"},{"issue":"5","key":"10.1016\/j.autrev.2023.103339_bb0070","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/jocd.13131","article-title":"Evaluation of complete blood cell and inflammatory parameters in patients with alopecia areata: their association with disease severity","volume":"19","author":"\u0130slamo\u011flu","year":"2020","journal-title":"J Cosmet Dermatol"},{"issue":"3 PG-236-9","key":"10.1016\/j.autrev.2023.103339_bb0075","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jdermsci.2008.01.004","article-title":"Serum BAFF and APRIL levels in patients with alopecia areata","volume":"50","author":"Kuwano","year":"2008","journal-title":"J Dermatol Sci"},{"issue":"10","key":"10.1016\/j.autrev.2023.103339_bb0080","first-page":"24","article-title":"Macrophage migration inhibitory factor in alopecia Areata and vitiligo: a case-controlled serological study","volume":"13","author":"Eldesouky","year":"2020","journal-title":"J Clin Aesthet Dermatol"},{"issue":"10 PG-493-8","key":"10.1016\/j.autrev.2023.103339_bb0085","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00403-006-0717-6","article-title":"Serum anti-Fcgamma receptor autoantibodies in patients with alopecia areata","volume":"298","author":"Kuwano","year":"2007","journal-title":"Arch Dermatol Res"},{"issue":"3 PG-113-117","key":"10.1016\/j.autrev.2023.103339_bb0090","first-page":"113","article-title":"Tumor necrosis factor-like weak inducer of apoptosis: a novel serum marker in patients with severe alopecia","volume":"11","author":"Al Taweel","year":"2019","journal-title":"Int J Trichol"},{"issue":"6 PG-1299-304","key":"10.1016\/j.autrev.2023.103339_bb0095","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/bjd.12980","article-title":"Vitamin D deficiency in alopecia areata","volume":"170","author":"Aksu Cerman","year":"2014","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.autrev.2023.103339_bb0100","first-page":"43","article-title":"The influence of osteopontin on the pathogenesis of alopecia areata and its association with disease severity","volume":"21","author":"Nasiri","year":"2018","journal-title":"Iran J Dermatol"},{"issue":"4 PG-577-584","key":"10.1016\/j.autrev.2023.103339_bb0105","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s10238-018-0511-8","article-title":"An investigation of vitamin D status in alopecia areata","volume":"18","author":"Gade","year":"2018","journal-title":"Clin Exp Med"},{"issue":"3 PG-295-299","key":"10.1016\/j.autrev.2023.103339_bb0110","first-page":"295","article-title":"Serum and tissue angiotensin-converting enzyme in patients with alopecia areata","volume":"85","author":"Fahim","year":"2019","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103339_bb0115","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/jcla.21731","article-title":"Serum level of macrophage migration inhibitory factor (MIF) in Egyptians with alopecia areata and its relation to the clinical severity of the disease","volume":"29","author":"Younan","year":"2015","journal-title":"J Clin Lab Anal"},{"issue":"1 PG-129-138","key":"10.1016\/j.autrev.2023.103339_bb0120","first-page":"129","article-title":"Ischemic modified albumin as a new biomarker in predicting oxidative stress in alopecia areata. Turkish","volume":"49","author":"Atas","year":"2019","journal-title":"J Med Sci"},{"issue":"4 PG-837-44","key":"10.1016\/j.autrev.2023.103339_bb0125","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/j.1365-2133.2011.10482.x","article-title":"Increased retinol-binding protein (RBP) 4 and anti-RBP4 antibody in alopecia areata","volume":"165","author":"Ahn","year":"2011","journal-title":"Br J Dermatol"},{"issue":"4 PG-407-410","key":"10.1016\/j.autrev.2023.103339_bb0130","doi-asserted-by":"crossref","first-page":"407","DOI":"10.4103\/ijd.IJD_677_16","article-title":"Vitamin D Level in Alopecia Areata","volume":"62","author":"Bhat","year":"2017","journal-title":"Indian J Dermatol"},{"issue":"6 PG-1236-43","key":"10.1016\/j.autrev.2023.103339_bb0135","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1365-2133.2011.10597.x","article-title":"Demonstration of autoantibodies against tyrosine hydroxylase in patients with alopecia areata","volume":"165","author":"Kemp","year":"2011","journal-title":"Br J Dermatol"},{"issue":"11 PG-881-5","key":"10.1016\/j.autrev.2023.103339_bb0140","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/1346-8138.12273","article-title":"Serum thymus and activation-regulated chemokine as disease activity and response biomarker in alopecia areata","volume":"40","author":"Inui","year":"2013","journal-title":"J Dermatol"},{"issue":"10","key":"10.1016\/j.autrev.2023.103339_bb0150","doi-asserted-by":"crossref","first-page":"4668","DOI":"10.15419\/bmrat.v8i10.702","article-title":"Evaluation of serum levels of IL-6, IL-10, and TNF-a in alopecia areata patients: a systematic review and meta-analysis","volume":"8","author":"Torkestani","year":"2021","journal-title":"Biomed Res Ther"},{"issue":"12","key":"10.1016\/j.autrev.2023.103339_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/cells10123397","article-title":"The role of serum Th1, Th2, and Th17 cytokines in patients with alopecia Areata: clinical implications","volume":"10","author":"Wa\u015bkiel-Burnat","year":"2021","journal-title":"Cells."},{"issue":"11","key":"10.1016\/j.autrev.2023.103339_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18112238","article-title":"Systemic inflammation, oxidative damage to nucleic acids, and metabolic syndrome in the pathogenesis of psoriasis","volume":"18","author":"Borska","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.autrev.2023.103339_bb0165","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1111\/jocd.13814","article-title":"Cross talk between oxidative stress and inflammation in alopecia areata","volume":"20","author":"Mustafa","year":"2021","journal-title":"J Cosmet Dermatol"},{"issue":"Spec Issue","key":"10.1016\/j.autrev.2023.103339_bb0170","first-page":"43","article-title":"Oxidative stress and alopecia areata","volume":"8","author":"Prie","year":"2015","journal-title":"J Med Life"},{"key":"10.1016\/j.autrev.2023.103339_bb0175","doi-asserted-by":"crossref","first-page":"7194","DOI":"10.1111\/jocd.15460","article-title":"Evaluation of the serum C-reactive protein\u2013albumin ratio and its relationship with disease severity IN alopecia areata: a prospective case\u2013control study","volume":"21","author":"Kalayc\u0131","year":"2022","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.autrev.2023.103339_bb0180","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1136\/jclinpath-2014-202493","article-title":"Gene of the month: interleukin 6 (IL-6)","volume":"67","author":"Ataie-Kachoie","year":"2014","journal-title":"J Clin Pathol"},{"issue":"10","key":"10.1016\/j.autrev.2023.103339_bb0185","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6 in inflammation, immunity, and disease","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"3","key":"10.1016\/j.autrev.2023.103339_bb0190","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1042\/bj2650621","article-title":"Interleukin-6 and the acute phase response","volume":"265","author":"Heinrich","year":"1990","journal-title":"Biochem J"},{"key":"10.1016\/j.autrev.2023.103339_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/5693572","article-title":"Increased serum levels of IFN-\u03b3, IL-1\u03b2, and IL-6 in patients with alopecia Areata and nonsegmental vitiligo","volume":"2020","author":"Tomaszewska","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.autrev.2023.103339_bb0200","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/exd.14129","article-title":"Understanding the significance of cytokines and chemokines in the pathogenesis of alopecia areata","volume":"29","author":"Ito","year":"2020","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.autrev.2023.103339_bb0205","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/ijd.12808","article-title":"T-helper 17 cytokines (interleukins 17, 21, 22, and 6, and tumor necrosis factor-\u03b1) in patients with alopecia areata: association with clinical type and severity","volume":"55","author":"Atwa","year":"2016","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.autrev.2023.103339_bb0210","doi-asserted-by":"crossref","first-page":"491S","DOI":"10.1093\/ajcn\/88.2.491S","article-title":"From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health","volume":"88","author":"Norman","year":"2008","journal-title":"Am J Clin Nutr"},{"issue":"6 Suppl","key":"10.1016\/j.autrev.2023.103339_bb0215","doi-asserted-by":"crossref","first-page":"1689S","DOI":"10.1093\/ajcn\/80.6.1689S","article-title":"Overview of general physiologic features and functions of vitamin D","volume":"80","author":"DeLuca","year":"2004","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"10.1016\/j.autrev.2023.103339_bb0220","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2310\/JIM.0b013e31821b8755","article-title":"Vitamin D and the immune system","volume":"59","author":"Aranow","year":"2011","journal-title":"J Invest Med"},{"key":"10.1016\/j.autrev.2023.103339_bb0225","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/ijd.13851","article-title":"Correlation of vitamin D and vitamin D receptor expression in patients with alopecia areata: a clinical paradigm","volume":"57","author":"Daroach","year":"2018","journal-title":"Int J Derm"},{"key":"10.1016\/j.autrev.2023.103339_bb0230","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4103\/idoj.IDOJ_84_18","article-title":"Evaluation of association of vitamin D in alopecia areata: a case-control study of 100 patients in a tertiary rural hospital of southern India","volume":"10","author":"Siddappa","year":"2019","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.autrev.2023.103339_bb0235","doi-asserted-by":"crossref","first-page":"e31089","DOI":"10.1097\/MD.0000000000031089","article-title":"Vitamin D supplementation for patients with alopecia areata: a protocol for systematic review and meta-analysis","volume":"101","author":"Zhu","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2023.103339_bb0240","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1111\/jocd.14844","article-title":"Intralesional vitamin D3 in treatment of alopecia areata: a randomized controlled clinical trial","volume":"21","author":"Rashad","year":"2022","journal-title":"J Cosmet Dermatol"},{"issue":"9","key":"10.1016\/j.autrev.2023.103339_bb0245","first-page":"5285","article-title":"Vitamin D and alopecia areata: possible roles in pathogenesis and potential implications for therapy","volume":"11","author":"Lin","year":"2019","journal-title":"Am J Transl Res"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223000733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223000733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:29:09Z","timestamp":1761600549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997223000733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":48,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S1568997223000733"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103339","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers in alopecia Areata: A systematic review and meta-analysis.","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103339","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103339"}}